Cargando…
The Risk of Bleeding and Adverse Events with Clopidogrel in Elective Hip and Knee Arthroplasty Patients
Orthopedic surgeons often face a clinical dilemma on how to manage antiplatelet therapies during the time of surgery. This retrospective study is aimed to investigate the bleeding risk and adverse events in patients who hold or keep clopidogrel during elective major joints arthroplasty. Two hundred...
Autores principales: | Wu, Cheng-Ta, Lien, Tzu-Hsien, Chen, I-Ling, Wang, Jun-Wen, Ko, Jih-Yang, Lee, Mel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999348/ https://www.ncbi.nlm.nih.gov/pubmed/35407361 http://dx.doi.org/10.3390/jcm11071754 |
Ejemplares similares
-
Impact of Clopidogrel Stop Interval on Major Adverse Bleeding Events in Cardiac Surgery
por: Huo, Bright, et al.
Publicado: (2021) -
Is Routine Hemoglobin Monitoring Necessary after Elective Hip and Knee Arthroplasty?
por: Hennessy, Orla, et al.
Publicado: (2020) -
Lupus and Perioperative Complications in Elective Primary Total Hip or Knee Arthroplasty
por: Aziz, Keith T., et al.
Publicado: (2020) -
Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty
por: Santana, Daniel C., et al.
Publicado: (2021) -
Thromboelastography in elective total hip arthroplasty
por: Lloyd-Donald, Patryck, et al.
Publicado: (2021)